These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3877311)

  • 21. The effects of verapamil on the locomotor-activating properties of corticotropin releasing factor (CRF) in the rat.
    Swerdlow NR; Koob GF; Aldenhoff JB
    Psychoneuroendocrinology; 1986; 11(2):237-40. PubMed ID: 3489244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress and corticotropin-releasing factor potentiate center region activity of mice in an open field.
    Lee EH; Tang YP; Chai CY
    Psychopharmacology (Berl); 1987; 93(3):320-3. PubMed ID: 3124162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of radio-frequency lesions of the nucleus accumbens on d-amphetamine-induced locomotor and rearing behavior in rats.
    Kehne JH; Sant WW; Sorenson CA
    Psychopharmacology (Berl); 1981; 75(4):363-7. PubMed ID: 6803281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
    Kalivas PW; Duffy P; Latimer LG
    J Pharmacol Exp Ther; 1987 Sep; 242(3):757-63. PubMed ID: 3498816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
    Britton KT; Lee G; Vale W; Rivier J; Koob GF
    Brain Res; 1986 Mar; 369(1-2):303-6. PubMed ID: 3008937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats.
    Eaves M; Thatcher-Britton K; Rivier J; Vale W; Koob GF
    Peptides; 1985; 6(5):923-6. PubMed ID: 3878503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic ethanol exposure potentiates the locomotor-activating effects of corticotropin-releasing factor (CRF) in rats.
    Ehlers CL; Chaplin RI
    Regul Pept; 1987 Dec; 19(5-6):345-53. PubMed ID: 3501867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats.
    Sarnyai Z; Höhn J; Szabó G; Penke B
    Life Sci; 1992; 51(26):2019-24. PubMed ID: 1335535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
    Dalia A; Uretsky NJ; Wallace LJ
    Brain Res; 1998 Mar; 788(1-2):111-7. PubMed ID: 9554973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABA and glutamate interact in the substantia innominata/lateral preoptic area to modulate locomotor activity.
    Shreve PE; Uretsky NJ
    Pharmacol Biochem Behav; 1991 Feb; 38(2):385-8. PubMed ID: 1676174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area.
    Sirinathsinghji DJ
    Brain Res; 1986 Jun; 375(1):49-56. PubMed ID: 3013371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of morphine in the nucleus accumbens on stimulant-induced locomotion.
    Layer RT; Uretsky NJ; Wallace LJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):21-6. PubMed ID: 1685784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
    Tronci E; Simola N; Carta AR; De Luca MA; Morelli M
    J Neurochem; 2006 Aug; 98(4):1078-89. PubMed ID: 16771831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced dopamine metabolism in accumbens leads to motor activity and concurrently to increased output from nondopamine neurons in ventral tegmental area and substantia nigra.
    Olds ME
    Physiol Behav; 1992 Jan; 51(1):39-50. PubMed ID: 1311110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens.
    Vezina P; Blanc G; Glowinski J; Tassin JP
    Synapse; 1994 Feb; 16(2):104-12. PubMed ID: 8197574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor enhances locomotion and medullary neuronal firing in an amphibian.
    Lowry CA; Rose JD; Moore FL
    Horm Behav; 1996 Mar; 30(1):50-9. PubMed ID: 8724179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion.
    Kim JH; Vezina P
    J Pharmacol Exp Ther; 1998 Jan; 284(1):317-22. PubMed ID: 9435194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticotropin releasing factor induces anxiogenic locomotion in trout and alters serotonergic and dopaminergic activity.
    Carpenter RE; Watt MJ; Forster GL; Øverli Ø; Bockholt C; Renner KJ; Summers CH
    Horm Behav; 2007 Dec; 52(5):600-11. PubMed ID: 17826776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.